RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Karam F. Soliman to Histone Deacetylase Inhibitors

Back to Details
This is a "connection" page, showing publications Karam F. Soliman has written about Histone Deacetylase Inhibitors.
Karam F. Soliman
Connection Strength
1.195
Histone Deacetylase Inhibitors
  1. Mazzio EA, Soliman KFA. Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A. Cancer Genomics Proteomics. 2018 Sep-Oct; 15(5):349-364.
    View in: PubMed
    Score: 0.632
  2. Mazzio EA, Soliman KF. HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells. Cancer Genomics Proteomics. 2017 01 02; 14(1):17-33.
    View in: PubMed
    Score: 0.563
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support